Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 210

1.

The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort.

Damotte D, Warren S, Arrondeau J, Boudou-Rouquette P, Mansuet-Lupo A, Biton J, Ouakrim H, Alifano M, Gervais C, Bellesoeur A, Kramkimel N, Tlemsani C, Burroni B, Duche A, Letourneur F, Si H, Halpin R, Creasy T, Herbst R, Ren X, Morel P, Cesano A, Goldwasser F, Leroy K.

J Transl Med. 2019 Nov 4;17(1):357. doi: 10.1186/s12967-019-2100-3.

2.

[Guidelines for the macroscopic management of surgically resected lung carcinoma].

Mansuet-Lupo A, Filaire M, Chaffanjon P, Alifano M, Forest F, Gibault L, Vignaud JM, Brevet M, Hofman V, Rouquette I, Antoine M, Cazes A, Damotte D, Lantuejoul S; pour le groupe de pathologistes thoraciques de valorisation de l’expertise, de la recherche et de l’innovation (PATTERN), Fondation Synergie Lyon Cancer.

Ann Pathol. 2019 Oct 8. pii: S0242-6498(19)30106-3. doi: 10.1016/j.annpat.2019.05.008. [Epub ahead of print] French.

PMID:
31604575
3.

Risk factors associated with myasthenia gravis in thymoma patients: The potential role of thymic germinal centers.

Lefeuvre CM, Payet CA, Fayet OM, Maillard S, Truffault F, Bondet V, Duffy D, de Montpreville V, Ghigna MR, Fadel E, Mansuet-Lupo A, Alifano M, Validire P, Gossot D, Behin A, Eymard B, Berrih-Aknin S, Le Panse R.

J Autoimmun. 2019 Oct 5:102337. doi: 10.1016/j.jaut.2019.102337. [Epub ahead of print]

PMID:
31594658
4.

Hypermetabolism is an independent prognostic factor of survival in metastatic non-small cell lung cancer patients.

Jouinot A, Ulmann G, Vazeille C, Durand JP, Boudou-Rouquette P, Arrondeau J, Tlemsani C, Fournel L, Alifano M, Wislez M, Chapron J, Le Bris C, Mansuet-Lupo A, Damotte D, Neveux N, De Bandt JP, Alexandre J, Cynober L, Goldwasser F.

Clin Nutr. 2019 Aug 10. pii: S0261-5614(19)30315-2. doi: 10.1016/j.clnu.2019.08.003. [Epub ahead of print]

PMID:
31443979
5.

Paraneoplastic hyperleukocytosis mimicking hematologic malignancy revealing a localized lung cancer.

Marouf A, Chapuis N, Alary AS, Burroni B, Kosmider O, Alifano M, Bouscary D.

Ann Thorac Surg. 2019 Aug 10. pii: S0003-4975(19)31164-6. doi: 10.1016/j.athoracsur.2019.06.064. [Epub ahead of print]

PMID:
31408646
6.

Cisplatin increases PD-L1 expression and optimizes immune check-point blockade in non-small cell lung cancer.

Fournel L, Wu Z, Stadler N, Damotte D, Lococo F, Boulle G, Ségal-Bendirdjian E, Bobbio A, Icard P, Trédaniel J, Alifano M, Forgez P.

Cancer Lett. 2019 Nov 1;464:5-14. doi: 10.1016/j.canlet.2019.08.005. Epub 2019 Aug 9.

PMID:
31404614
7.

Clinical Characteristics, Molecular Phenotyping, and Management of Isolated Adrenal Metastases From Lung Cancer.

Mazzella A, Loi M, Mansuet-Lupo A, Bobbio A, Blons H, Damotte D, Alifano M.

Clin Lung Cancer. 2019 Nov;20(6):405-411. doi: 10.1016/j.cllc.2019.06.003. Epub 2019 Jun 13.

PMID:
31281051
8.

Endoscopic and surgical treatment for bronchopleural fistula after major lung resection: an enduring challenge.

Cusumano G, Alifano M, Lococo F.

J Thorac Dis. 2019 May;11(Suppl 9):S1351-S1356. doi: 10.21037/jtd.2019.03.102. No abstract available.

9.

Obstructive lung disease in smokers and never smokers: further insights in patient-related approach in lung cancer understanding.

Alifano M.

J Thorac Dis. 2019 May;11(Suppl 9):S1310-S1312. doi: 10.21037/jtd.2019.04.53. No abstract available.

10.

NF1 mutations identify molecular and clinical subtypes of lung adenocarcinomas.

Tlemsani C, Pécuchet N, Gruber A, Laurendeau I, Danel C, Riquet M, Le Pimpec-Barthes F, Fabre E, Mansuet-Lupo A, Damotte D, Alifano M, Luscan A, Rousseau B, Vidaud D, Varin J, Parfait B, Bieche I, Leroy K, Laurent-Puig P, Terris B, Blons H, Vidaud M, Pasmant E.

Cancer Med. 2019 Aug;8(9):4330-4337. doi: 10.1002/cam4.2175. Epub 2019 Jun 14.

11.

Gluconeogenesis of Cancer Cells Is Disrupted by Citrate.

Icard P, Wu Z, Alifano M, Fournel L.

Trends Cancer. 2019 May;5(5):265-266. doi: 10.1016/j.trecan.2019.03.002. Epub 2019 Apr 9. No abstract available.

PMID:
31174837
12.

Automated image analysis of NSCLC biopsies to predict response to anti-PD-L1 therapy.

Althammer S, Tan TH, Spitzmüller A, Rognoni L, Wiestler T, Herz T, Widmaier M, Rebelatto MC, Kaplon H, Damotte D, Alifano M, Hammond SA, Dieu-Nosjean MC, Ranade K, Schmidt G, Higgs BW, Steele KE.

J Immunother Cancer. 2019 May 6;7(1):121. doi: 10.1186/s40425-019-0589-x.

13.

En Bloc Resection of Thoracic Tumors Invading the Spine: A Single-Center Experience.

Zhang XM, Fournel L, Lupo A, Canny E, Bobbio A, Lasry S, Regnard JF, Sailhan F, Alifano M.

Ann Thorac Surg. 2019 Jul;108(1):227-234. doi: 10.1016/j.athoracsur.2019.02.019. Epub 2019 Mar 15.

PMID:
30885851
14.

Epidemiology and Appropriateness of Antibiotic Prescribing in Severe Pneumonia After Lung Resection.

Kernéis S, Blanc K, Caliez J, Canouï E, Loubinoux J, Gauzit R, Nguyen YL, Casetta A, Lefebvre A, Regnard JF, Bouam S, Alifano M, Rabbat A.

Ann Thorac Surg. 2019 Jul;108(1):196-202. doi: 10.1016/j.athoracsur.2019.01.072. Epub 2019 Mar 7.

PMID:
30853591
15.

Proposal for a Combined Histomolecular Algorithm to Distinguish Multiple Primary Adenocarcinomas from Intrapulmonary Metastasis in Patients with Multiple Lung Tumors.

Mansuet-Lupo A, Barritault M, Alifano M, Janet-Vendroux A, Zarmaev M, Biton J, Velut Y, Le Hay C, Cremer I, Régnard JF, Fournel L, Rance B, Wislez M, Laurent-Puig P, Herbst R, Damotte D, Blons H.

J Thorac Oncol. 2019 May;14(5):844-856. doi: 10.1016/j.jtho.2019.01.017. Epub 2019 Feb 2.

PMID:
30721797
16.

Interconnection between Metabolism and Cell Cycle in Cancer.

Icard P, Fournel L, Wu Z, Alifano M, Lincet H.

Trends Biochem Sci. 2019 Jun;44(6):490-501. doi: 10.1016/j.tibs.2018.12.007. Epub 2019 Jan 14. Review.

PMID:
30655165
17.

Modulation of lung cancer cell plasticity and heterogeneity with the restoration of cisplatin sensitivity by neurotensin antibody.

Wu Z, Fournel L, Stadler N, Liu J, Boullier A, Hoyeau N, Fléjou JF, Duchatelle V, Djebrani-Oussedik N, Agopiantz M, Ségal-Bendirdjian E, Gompel A, Alifano M, Melander O, Trédaniel J, Forgez P.

Cancer Lett. 2019 Mar 1;444:147-161. doi: 10.1016/j.canlet.2018.12.007. Epub 2018 Dec 21.

PMID:
30583074
18.

Toll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cells.

Dajon M, Iribarren K, Petitprez F, Marmier S, Lupo A, Gillard M, Ouakrim H, Victor N, Vincenzo DB, Joubert PE, Kepp O, Kroemer G, Alifano M, Damotte D, Cremer I.

Oncoimmunology. 2018 Oct 11;8(1):e1505174. doi: 10.1080/2162402X.2018.1505174. eCollection 2019.

19.

Synchronous Oligometastatic Lung Cancer Deserves a Dedicated Management.

Loi M, Mazzella A, Mansuet-Lupo A, Bobbio A, Canny E, Magdeleinat P, Régnard JF, Damotte D, Trédaniel J, Alifano M.

Ann Thorac Surg. 2019 Apr;107(4):1053-1059. doi: 10.1016/j.athoracsur.2018.10.029. Epub 2018 Nov 23.

PMID:
30476480
20.

Clinical presentation and treatment of catameinal pneumothorax and endometriosis-related pneumothorax.

Fournel L, Bobbio A, Robin E, Canny-Hamelin E, Alifano M, Regnard JF.

Expert Rev Respir Med. 2018 Dec;12(12):1031-1036. doi: 10.1080/17476348.2018.1551133. Epub 2018 Nov 27. Review.

PMID:
30457394
21.

Citrate targets FBPase and constitutes an emerging novel approach for cancer therapy.

Icard P, Fournel L, Coquerel A, Gligorov J, Alifano M, Lincet H.

Cancer Cell Int. 2018 Nov 8;18:175. doi: 10.1186/s12935-018-0676-y. eCollection 2018.

22.

Patients experiencing early acute respiratory failure have high postoperative mortality after pneumonectomy.

Blanc K, Dechartres A, Zaimi R, Lefebvre A, Janet-Vendroux A, Fournel L, Dermine H, Lorut C, Becanne X, Hamelin-Canny E, Bobbio A, Roche N, Regnard JF, Alifano M, Rabbat A.

J Thorac Cardiovasc Surg. 2018 Dec;156(6):2368-2376. doi: 10.1016/j.jtcvs.2018.08.113. Epub 2018 Sep 27.

PMID:
30449587
23.

Postoperative outcomes of frequent exacerbator patients with Chronic Obstructive Pulmonary Disease after resection of Non-Small Cells Lung Cancer.

Demiri S, Lorut C, Rabbat A, Luu van Lang D, Lefebvre A, Regnard JF, Samama CM, Dusser D, Roche N, Alifano M.

COPD. 2018 Jun-Aug;15(4):361-368. doi: 10.1080/15412555.2018.1519784. Epub 2018 Oct 30.

PMID:
30375895
24.

Sarcopenia in resected non-small cell lung cancer: let's move to patient-directed strategies.

Icard P, Iannelli A, Lincet H, Alifano M.

J Thorac Dis. 2018 Sep;10(Suppl 26):S3138-S3142. doi: 10.21037/jtd.2018.08.34. No abstract available.

25.

[IHC, FISH, CISH, NGS in non-small cell lung cancer: What changes in the biomarker era?]

Hamard C, Mignard X, Pecuchet N, Mathiot N, Blons H, Laurent-Puig P, Leroy K, Lupo A, Chapron J, Giraud F, Arrondeau J, Goldwasser F, Alifano M, Damotte D, Wislez M.

Rev Pneumol Clin. 2018 Oct;74(5):327-338. doi: 10.1016/j.pneumo.2018.09.013. Epub 2018 Oct 19. Review. French.

PMID:
30343945
26.

[Biomarkers predictive of PD1/PD-L1 immunotherapy in non-small cell lung cancer].

Lupo A, Alifano M, Wislez M, Boulle G, Velut Y, Biton J, Cremer I, Goldwasser F, Leroy K, Damotte D.

Rev Pneumol Clin. 2018 Oct;74(5):339-350. doi: 10.1016/j.pneumo.2018.09.010. Epub 2018 Oct 15. Review. French.

PMID:
30337201
27.

[Malignant pleural mesothelioma: The role of surgery].

Fournel L, Janet-Vendroux A, Canny-Hamelin E, Mansuet-Lupo A, Guinet C, Bobbio A, Damotte D, Alifano M.

Rev Pneumol Clin. 2018 Oct;74(5):351-358. doi: 10.1016/j.pneumo.2018.09.006. Epub 2018 Oct 11. Review. French.

PMID:
30316650
28.

Anti-tumour effect of low molecular weight heparin in localised lung cancer: a phase III clinical trial.

Meyer G, Besse B, Doubre H, Charles-Nelson A, Aquilanti S, Izadifar A, Azarian R, Monnet I, Lamour C, Descourt R, Oliviero G, Taillade L, Chouaid C, Giraud F, Falcoz PE, Revel MP, Westeel V, Dixmier A, Tredaniel J, Dehette S, Decroisette C, Prevost A, Pichon E, Fabre E, Soria JC, Friard S, Stern JB, Jabot L, Dennewald G, Pavy G, Petitpretz P, Tourani JM, Alifano M, Chatellier G, Girard P.

Eur Respir J. 2018 Oct 4;52(4). pii: 1801220. doi: 10.1183/13993003.01220-2018. Print 2018 Oct.

PMID:
30262574
29.

Hereditary multiple exostoses of the ribs as an uncommon cause of pneumothorax: A case report.

Dumazet A, Launois C, Dury S, Sailhan F, Alifano M, Dewolf M, Lebargy F, Deslee G, Perotin JM.

Medicine (Baltimore). 2018 Aug;97(35):e11894. doi: 10.1097/MD.0000000000011894.

30.

[Analysis of immune microenvironment by multiplex immunohistochemistry in locally advanced non-small cell lung cancer: Principles and perspectives].

Boulle G, Velut Y, Boni A, Lupo A, Alifano M, Trédaniel J, Giraud P, Damotte D.

Cancer Radiother. 2018 Oct;22(6-7):688-693. doi: 10.1016/j.canrad.2018.07.031. Epub 2018 Aug 18. Review. French.

PMID:
30131267
31.

Extracellular Citrate and Cancer Metabolism-Letter.

Icard P, Fournel L, Alifano M, Lincet H.

Cancer Res. 2018 Sep 1;78(17):5176. doi: 10.1158/0008-5472.CAN-18-1666. Epub 2018 Aug 16. No abstract available.

32.

Early acute respiratory distress syndrome after pneumonectomy: Presentation, management, and short- and long-term outcomes.

Blanc K, Zaimi R, Dechartres A, Lefebvre A, Janet-Vendroux A, Hamelin-Canny E, Roche N, Alifano M, Rabbat A.

J Thorac Cardiovasc Surg. 2018 Oct;156(4):1706-1714.e5. doi: 10.1016/j.jtcvs.2018.06.021. Epub 2018 Jul 2.

PMID:
30060929
33.

How the Warburg effect supports aggressiveness and drug resistance of cancer cells?

Icard P, Shulman S, Farhat D, Steyaert JM, Alifano M, Lincet H.

Drug Resist Updat. 2018 May;38:1-11. doi: 10.1016/j.drup.2018.03.001. Epub 2018 Mar 20. Review.

PMID:
29857814
34.

TP53, STK11, and EGFR Mutations Predict Tumor Immune Profile and the Response to Anti-PD-1 in Lung Adenocarcinoma.

Biton J, Mansuet-Lupo A, Pécuchet N, Alifano M, Ouakrim H, Arrondeau J, Boudou-Rouquette P, Goldwasser F, Leroy K, Goc J, Wislez M, Germain C, Laurent-Puig P, Dieu-Nosjean MC, Cremer I, Herbst R, Blons H, Damotte D.

Clin Cancer Res. 2018 Nov 15;24(22):5710-5723. doi: 10.1158/1078-0432.CCR-18-0163. Epub 2018 May 15.

35.

Predictors of post-pneumonectomy respiratory failure and ARDS: usefulness of normalized pulmonary artery diameter.

Peretti M, Hervochon R, Loi M, Blanc K, Roche N, Alifano M.

Intensive Care Med. 2018 Aug;44(8):1357-1359. doi: 10.1007/s00134-018-5206-9. Epub 2018 May 11. No abstract available.

PMID:
29752525
36.

Expression of LLT1 and its receptor CD161 in lung cancer is associated with better clinical outcome.

Braud VM, Biton J, Becht E, Knockaert S, Mansuet-Lupo A, Cosson E, Damotte D, Alifano M, Validire P, Anjuère F, Cremer I, Girard N, Gossot D, Seguin-Givelet A, Dieu-Nosjean MC, Germain C.

Oncoimmunology. 2018 Jan 29;7(5):e1423184. doi: 10.1080/2162402X.2017.1423184. eCollection 2018.

37.

A bicenter study on adjuvant surgery following treatment with tyrosine kinase inhibitors in patients with advanced lung adenocarcinoma.

Fournel L, Falcoz PE, Mansuet-Lupo A, Garelli E, Lococo F, Alifano M.

Interact Cardiovasc Thorac Surg. 2018 Oct 1;27(4):598-601. doi: 10.1093/icvts/ivy120.

PMID:
29672751
38.

Oropharyngeal and nasopharyngeal decontamination with chlorhexidine gluconate in lung cancer surgery: a randomized clinical trial.

D'Journo XB, Falcoz PE, Alifano M, Le Rochais JP, D'Annoville T, Massard G, Regnard JF, Icard P, Marty-Ane C, Trousse D, Doddoli C, Orsini B, Edouard S, Million M, Lesavre N, Loundou A, Baumstarck K, Peyron F, Honoré S, Dizier S, Charvet A, Leone M, Raoult D, Papazian L, Thomas PA.

Intensive Care Med. 2018 May;44(5):578-587. doi: 10.1007/s00134-018-5156-2. Epub 2018 Apr 18.

PMID:
29671041
39.

Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment.

Peranzoni E, Lemoine J, Vimeux L, Feuillet V, Barrin S, Kantari-Mimoun C, Bercovici N, Guérin M, Biton J, Ouakrim H, Régnier F, Lupo A, Alifano M, Damotte D, Donnadieu E.

Proc Natl Acad Sci U S A. 2018 Apr 24;115(17):E4041-E4050. doi: 10.1073/pnas.1720948115. Epub 2018 Apr 9.

40.

Impaired Tumor-Infiltrating T Cells in Patients with Chronic Obstructive Pulmonary Disease Impact Lung Cancer Response to PD-1 Blockade.

Biton J, Ouakrim H, Dechartres A, Alifano M, Mansuet-Lupo A, Si H, Halpin R, Creasy T, Bantsimba-Malanda C, Arrondeau J, Goldwasser F, Boudou-Rouquette P, Fournel L, Roche N, Burgel PR, Goc J, Devi-Marulkar P, Germain C, Dieu-Nosjean MC, Cremer I, Herbst R, Damotte D.

Am J Respir Crit Care Med. 2018 Oct 1;198(7):928-940. doi: 10.1164/rccm.201706-1110OC.

PMID:
29518341
41.

Dimethyl fumarate is highly cytotoxic in KRAS mutated cancer cells but spares non-tumorigenic cells.

Bennett Saidu NE, Bretagne M, Mansuet AL, Just PA, Leroy K, Cerles O, Chouzenoux S, Nicco C, Damotte D, Alifano M, Borghese B, Goldwasser F, Batteux F, Alexandre J.

Oncotarget. 2018 Jan 10;9(10):9088-9099. doi: 10.18632/oncotarget.24144. eCollection 2018 Feb 6.

42.

Dedifferentiated primary mediastinal liposarcoma mimicking a thymic tumor.

Mansuet-Lupo A, Lococo F, Larousserie F, Alifano M, Saliceti R.

Pathologica. 2017 Dec;109(4):401-404.

PMID:
29449733
43.

Ex Vivo Imaging of Resident CD8 T Lymphocytes in Human Lung Tumor Slices Using Confocal Microscopy.

Peranzoni E, Bougherara H, Barrin S, Mansuet-Lupo A, Alifano M, Damotte D, Donnadieu E.

J Vis Exp. 2017 Dec 27;(130). doi: 10.3791/55709.

44.

Prognostic factors after pulmonary metastasectomy of colorectal cancers: a single-center experience.

Fournel L, Maria S, Seminel M, Nesci J, Mansuet-Lupo A, Guinet C, Magdeleinat P, Bobbio A, Regnard JF, Alifano M.

J Thorac Dis. 2017 Oct;9(Suppl 12):S1259-S1266. doi: 10.21037/jtd.2017.04.44.

45.

Inter-relationship between PD-L1 expression and clinic-pathological features and driver gene mutations in pulmonary sarcomatoid carcinomas.

Lococo F, Torricelli F, Rossi G, Alifano M, Damotte D, Rapicetta C, Tamagnini I, Cavazza A, Piana S, Galeone C, Paci M, Ciarrocchi A.

Lung Cancer. 2017 Nov;113:93-101. doi: 10.1016/j.lungcan.2017.09.009. Epub 2017 Sep 18.

PMID:
29110857
46.

Thoracic Endometriosis Syndrome Other Than Pneumothorax: Clinical and Pathological Findings.

Bobbio A, Canny E, Mansuet Lupo A, Lococo F, Legras A, Magdeleinat P, Regnard JF, Gompel A, Damotte D, Alifano M.

Ann Thorac Surg. 2017 Dec;104(6):1865-1871. doi: 10.1016/j.athoracsur.2017.06.049. Epub 2017 Oct 17.

PMID:
29054304
47.

Surgical Resection for Pulmonary Carcinoid: Long-Term Results of Multicentric Study-The Importance of Pathological N Status, More Than We Thought.

Cusumano G, Fournel L, Strano S, Damotte D, Charpentier MC, Galia A, Terminella A, Nicolosi M, Regnard JF, Alifano M.

Lung. 2017 Dec;195(6):789-798. doi: 10.1007/s00408-017-0056-8. Epub 2017 Oct 11.

PMID:
29022070
48.

The value of molecular techniques to diagnose Ureaplasma urealyticum and Nocardia farcinica pleuropneumonia in a patient with diffuse large B-cell lymphoma.

Canouï E, Blanc K, Loubinoux J, Valade S, Hamard C, Lefebvre A, Amorim S, Bébéar C, Rodriguez-Nava V, Lebeaux D, Launay O, Alifano M, Rabbat A, Kernéis S.

Int J Infect Dis. 2017 Nov;64:93-95. doi: 10.1016/j.ijid.2017.09.015. Epub 2017 Sep 22.

49.

Bacteria-driven peribronchial lymphoid neogenesis in bronchiectasis and cystic fibrosis.

Frija-Masson J, Martin C, Regard L, Lothe MN, Touqui L, Durand A, Lucas B, Damotte D, Alifano M, Fajac I, Burgel PR.

Eur Respir J. 2017 Apr 26;49(4). pii: 1601873. doi: 10.1183/13993003.01873-2016. Print 2017 Apr.

50.

Correlation between radiological and pathological features of operated ground glass nodules.

Fournel L, Etienne H, Mansuet Lupo A, Damotte D, Rouquette A, Revel MP, Guinet C, Alifano M, Regnard JF.

Eur J Cardiothorac Surg. 2017 Feb 1;51(2):248-254. doi: 10.1093/ejcts/ezw294. No abstract available.

PMID:
28186249

Supplemental Content

Loading ...
Support Center